These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23231482)

  • 41. Turning a new phage.
    Gravitz L
    Nat Med; 2012 Sep; 18(9):1318-20. PubMed ID: 22961150
    [No Abstract]   [Full Text] [Related]  

  • 42. Lysins to kill - a tale of viral weapons of mass destruction.
    O'Mahony J; Fenton M; Henry M; Sleator RD; Coffey A
    Bioeng Bugs; 2011; 2(6):306-8. PubMed ID: 22008941
    [No Abstract]   [Full Text] [Related]  

  • 43. Optimal bacteriophage mutation rates for phage therapy.
    Kysela DT; Turner PE
    J Theor Biol; 2007 Dec; 249(3):411-21. PubMed ID: 17904162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bacteriophages as an alternative strategy for fighting biofilm development.
    Parasion S; Kwiatek M; Gryko R; Mizak L; Malm A
    Pol J Microbiol; 2014; 63(2):137-45. PubMed ID: 25115107
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bacteriophage therapy.
    Sulakvelidze A; Alavidze Z; Morris JG
    Antimicrob Agents Chemother; 2001 Mar; 45(3):649-59. PubMed ID: 11181338
    [No Abstract]   [Full Text] [Related]  

  • 46. [Microbial antagonism in the therapy of infectious diseases].
    Ledermann W
    Rev Chilena Infectol; 2013 Aug; 30(4):446-50. PubMed ID: 24248116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Access to bacteriophage therapy: discouraging experiences from the human cell and tissue legal framework.
    Verbeken G; Huys I; De Vos D; De Coninck A; Roseeuw D; Kets E; Vanderkelen A; Draye JP; Rose T; Jennes S; Ceulemans C; Pirnay JP
    FEMS Microbiol Lett; 2016 Feb; 363(4):. PubMed ID: 26678555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Kinetics of phage-mediated biocontrol of bacteria.
    Abedon ST
    Foodborne Pathog Dis; 2009 Sep; 6(7):807-15. PubMed ID: 19459758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [A review of the regulatory framework for personalized bacteriophages registration].
    Landyshev NN; Voronko YG; Timoshina OY; Suslina SN; Akimkin VG; Miroshnikov KA
    Vopr Virusol; 2020 Nov; 65(5):259-266. PubMed ID: 33533209
    [TBL] [Abstract][Full Text] [Related]  

  • 50. On an invisible microbe antagonistic toward dysenteric bacilli: brief note by Mr. F. D'Herelle, presented by Mr. Roux. 1917.
    D'Herelle F
    Res Microbiol; 2007 Sep; 158(7):553-4. PubMed ID: 17855060
    [No Abstract]   [Full Text] [Related]  

  • 51. [Phage therapy: harmless viruses help destroy bacterial infections].
    van Bergen M; Wagenaar J
    Tijdschr Diergeneeskd; 2008 Jul 15-Aug 1; 133(14-15):618-21. PubMed ID: 18767304
    [No Abstract]   [Full Text] [Related]  

  • 52. [Bacteriophage therapy revisited].
    Kallings LO
    Lakartidningen; 2009 Oct 14-20; 106(42):2708. PubMed ID: 19972672
    [No Abstract]   [Full Text] [Related]  

  • 53. Revisiting phage therapy: new applications for old resources.
    Nobrega FL; Costa AR; Kluskens LD; Azeredo J
    Trends Microbiol; 2015 Apr; 23(4):185-91. PubMed ID: 25708933
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Searching for self-replicating antimicrobials.
    Cima G
    J Am Vet Med Assoc; 2010 Dec; 237(12):1336-9. PubMed ID: 21155672
    [No Abstract]   [Full Text] [Related]  

  • 55. At the Centennial of the Bacteriophage: Reviving the Overlooked Contribution of a Forgotten Pioneer, Richard Bruynoghe (1881-1957).
    Billiau A
    J Hist Biol; 2016 Aug; 49(3):559-80. PubMed ID: 26515105
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Bacteriophage therapy and colleague Martin Arrowsmith].
    Nevasaari K
    Duodecim; 2003; 119(14):1367. PubMed ID: 12916189
    [No Abstract]   [Full Text] [Related]  

  • 57. Use of phages to control Campylobacter spp.
    Janež N; Loc-Carrillo C
    J Microbiol Methods; 2013 Oct; 95(1):68-75. PubMed ID: 23830848
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recent advances in bacteriophage therapy: how delivery routes, formulation, concentration and timing influence the success of phage therapy.
    Ryan EM; Gorman SP; Donnelly RF; Gilmore BF
    J Pharm Pharmacol; 2011 Oct; 63(10):1253-64. PubMed ID: 21899540
    [TBL] [Abstract][Full Text] [Related]  

  • 59. When viruses were not in style: parallels in the histories of chicken sarcoma viruses and bacteriophages.
    Sankaran N
    Stud Hist Philos Biol Biomed Sci; 2014 Dec; 48 Pt B():189-99. PubMed ID: 25200095
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacteriophage therapy in children: facts and prospects.
    Fortuna W; Miedzybrodzki R; Weber-Dabrowska B; Górski A
    Med Sci Monit; 2008 Aug; 14(8):RA126-32. PubMed ID: 18668009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.